Antibodies and vaccines against Middle East respiratory syndrome coronavirus-Reference-Cited by-同舟云学术

Antibodies and vaccines against Middle East respiratory syndrome coronavirus

Published:2019-01-01 Issue:1 Volume:8 Page:841-856
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Xu Jiuyang¹^ORCID,Jia Wenxu¹,Wang Pengfei²,Zhang Senyan²,Shi Xuanling¹,Wang Xinquan²^ORCID,Zhang Linqi¹^ORCID

Affiliation:

1. Comprehensive AIDS Research Center, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, Tsinghua University School of Medicine, Beijing, People’s Republic of China

2. Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Collaborative Innovation Center for Biotherapy, Tsinghua University School of Life Sciences, Beijing, People’s Republic of China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://tandfonline.com/doi/pdf/10.1080/22221751.2019.1624482

Reference97 articles.

1. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

2. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003

3. A New Virus Isolated from the Human Respiratory Tract.

4. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease.

5. Identification of a new human coronavirus

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucosal immunity in upper and lower respiratory tract to MERS-CoV;Frontiers in Immunology;2024-08-30

2. Structure defining of ultrapotent neutralizing nanobodies against MERS-CoV with novel epitopes on receptor binding domain;PLOS Pathogens;2024-08-14

3. Dissecting humoral immune responses to an MVA-vectored MERS-CoV vaccine in humans using a systems serology approach;iScience;2024-08

4. Nanoparticles insert a three dimensional cavity structure of proteins for function inhibition: The Case of CeO2 and SARS-CoV-2;Nano Today;2024-04

5. ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks;Antibody Therapeutics;2023-12-12